David A. Siegel Guardant Health, Inc. Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 793,900 shares of GH stock, worth $22.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

793,900

Previous 807,300 1.66%

Holding current value

$22.9 Million

Previous $21.8 Million 25.0%

% of portfolio

0.04%

Previous 0.05%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $229,542 - $360,594	-13,400 Reduced 1.66%	793,900 $16.4 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $2.72 Million - $3.72 Million	-126,000 Reduced 13.5%	807,300 $21.8 Million
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $4.83 Million - $7.48 Million	187,100 Added 25.07%	933,300 $27.7 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $7.52 Million - $13.7 Million	359,200 Added 92.82%	746,200 $26.7 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $4.83 Million - $7.11 Million	210,700 Added 119.51%	387,000 $9.07 Million

Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $3.12 Million - $7.34 Million	122,800 Added 229.53%	176,300 $4.8 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $995,447 - $1.39 Million	22,800 Added 74.27%	53,500 $2.88 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $884,774 - $2.37 Million	30,700 New	30,700 $1.24 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $167,909 - $224,688	-1,700 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $2.67 Million - $4.03 Million	-24,300 Reduced 93.46%	1,700 $211,000
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $3.3 Million - $4.66 Million	26,000 New	26,000 $3.97 Million

Others Institutions Holding GH

# of Institutions

309

Shares Held

110M

Call Options Held

2.51M

Put Options Held

1.7M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.95B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account